Association of IL-10 and IL-6 gene polymorphisms with type 2 diabetes mellitus among Egyptian patients;Mısır'lı hastalarda tip 2 diyabet ile IL-10 ve IL-6 gen poliformizmi arasındaki i̇lişki

European Journal of General Medicine

Volumn 10, Issue 3, 2013, Pages 158-162

  Helaly, Mohamed Abdel Halem ^a   Hatata, El Sayed Zaki ^a   Abu Elmagd, Megahed ^a   Ibrahem, Eman Fathi ^b   Alsaid, Afaf ^c   El Aal, Ibrahim Ahmed Abd ^d   Settin, Ahmad ^c  

^a MANSOURA UNIVERSITY   (Egypt)

^b BENI SUEF UNIVERSITY   (Egypt)

^c MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

^d MANSOURA UNIVERSITY   (Egypt)

Author keywords

Egypt; Gene polymorphism; IL 10; IL 6; Type 2 diabetes

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; INTERLEUKIN 10; INTERLEUKIN 6;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DISEASE ASSOCIATION; DISEASE SEVERITY; EGYPT; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IL 10 GENE; IL 6 GENE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 84887372252     PISSN: 13043889     EISSN: None     Source Type: Journal    
DOI: 10.29333/ejgm/82250     Document Type: Article

References (25)

1. Harrison SA. Liver disease in patients with diabetes mellitus. J Clin Gastroenterol 2006; 40(1): 68-76.
2. Williams textbook of endocrinology. (12th ed. ed.). Philadelphia: Elsevier/Saunders pp. 1371-1435.
3. Sullivan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hill JO. Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care 2005; 28(7): 1599-603.
4. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27: 813-23.
5. Abdallah AN, Cucchi-Mouillot P, Biteau N, Cassaigne A, Haras D, Iron A. Analysis of the polymorphism of the tumor necrosis factor (TNF) gene and promotor and of circulating TNF-alpha levels in heart transplant patients suffering or not suffering from severe rejection. Eur J Immunogen 1999; 26: 249-55.
6. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immunity 1999; 1(1):3-19.
7. Ding Y, Kantarci A, Badwey JA, Hasturk H, Malabanan A, Van Dyke TE. Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus. J Immunol 2007; 179(1): 647-54.
8. Shiba T, Higashi N, Nishimura Y. Hyperglycemia due to insulin resistance caused by interferon-gamma. Diabet Med 1998; 15: 435-6.
9. Short AD, Catchpole B, Kennedy LJ, et al. Analysis of candidate susceptibility genes in canine diabetes. J Hered 2007; 98(5): 518-25.
10. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
11. Donnelly RP, Freeman SL, Hayes MP. Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes. J Immunol 1995; 155: 1420-7.
12. Ross JA. Dynamics of peripheral circulation B. Electrocardiography and disorders of cardiac rhythm. In West JB (ed.). Best and Taylor's, Physiological basis of medical practice. 11th edition, 1985; PP: 132-136.
13. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969;22(2):158-61.
14. Frier BM, Ashby JP, Nairn IM and Blairs JD. Plasma insulin, C-peptide and glucagons concentration in patients with insulin independent diabetes treated with chlorpropamide. Diab Metab 1981; 7(1): 45-9.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model of assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-9.
16. Kolla VK, Madhavi G, Pulla Reddy B, et al. Association of tumor necrosis factor alpha, interferon gamma and IL-10 gene polymorphisms with peripheral neuropathy in south Indian patients with type 2 DM. Arch Med Res 2009; 40(4): 276-84.
17. Wogensen L, Lee MS, Sarvetnick N. Production of IL-10 by islet cells accelerates immune-mediated destruction of beta cells in non obese diabetic mice. J Exp Med 1994 1;179(4):1379-84.
18. Settin A, Ismail A, El-Magd MA, El-Baz R, Kazamel A. Gene polymorphisms of TNF-alpha-308 (G/A), IL-10(-1082) (G/A), IL-6(-174) (G/C) and IL-1Ra (VNTR) in Egyptian cases with type 1 diabetes mellitus. Autoimmunity 2009; 42(1): 50-5
19. Scarpelli D, Cardellini M, Andreozzi F, et al. Varients of the interleukin-10 promotor gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian Italian subjects. Diabetes 2006; 55(5): 1529-33.
20. Tsiavou A, Hatziagelaki E, Chaidaroglou A, et al. TNF-α, TGF-beta1, IL-10, IL-6 gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus. J Clin Immunol 2004; 24(6): 591-9.
21. Kubaszek A, Pihlajamaki J, Punnonen K, Karhapää P, Vauhkonen I, Laakso M. The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 2003; 52: 558-61.
22. Herbert A, Liu C, Karamohamed S, Schiller J, Liu J, Yang Q, et al. The -174 IL-6 GG genotype is associated with a reduced risk of type 2 diabetes mellitus in a family sample from the National Heart, Lung and Blood Institute's Framingham Heart Study. Diabetologia 2005; 48(8):1492-5.
23. Stephens JW, Hurel SJ, Cooper JA, Acharya J, Miller GJ, Humphries SE. A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus. Mol Genet Metab 2004; 82: 180-6.
24. Qi L, van Dam RM, Meigs JB, Manson JE, Hunter D, Hu FB. Genetic variation in IL6 gene and type 2 diabetes: tagging- SNP haplotype analysis in large-scale case-control study and meta-analysis. Hum Mol Genet 2006; 15(11):1914-20.
25. Vozarova B, Fernandez-Real JM, Knowler WC, Gallart L, Hanson RL, Gruber JD, et al. The interleukin-6 (-174) G/C promotor polymorphism is associated with type 2 diabetes mellitus in Native American and Caucasians. Hum Genet 2003; 112: 409-13.